Quest Diagnostics logo

Quest Diagnostics

North America, New Jersey, United States, Secaucus

Description

Quest Diagnostics is a clinical laboratory that offers diagnostic testing, services, and information.

Investor Profile

Quest Diagnostics has made 6 investments, with 2 in the past 12 months and 17% as lead.

Stage Focus

  • Series B (50%)
  • Series Unknown (33%)
  • Series A (17%)

Country Focus

  • United States (67%)
  • Spain (33%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Health Diagnostics
  • Biopharma
  • Personal Health
  • Medical Device
  • Artificial Intelligence (Ai)
  • Machine Learning
  • Telehealth
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Quest Diagnostics frequently co-invest with?

Eventide
North America, Massachusetts, United States, Boston
Co-Investments: 2
Bain Capital Life Sciences
North America, Massachusetts, United States, Boston
Co-Investments: 1
Artis Ventures (AV)
North America, California, United States, San Francisco
Co-Investments: 1
BrightEdge Fund
North America, Georgia, United States, Atlanta
Co-Investments: 1
ArrowMark Partners
North America, Colorado, United States, Denver
Co-Investments: 1
DCVC Bio
North America, California, United States, San Francisco
Co-Investments: 1
IV
North America, Utah, United States, Salt Lake City
Co-Investments: 1
Andreessen Horowitz
North America, California, United States, Menlo Park
Co-Investments: 1
CC
North America, New York, United States, New York
Co-Investments: 1
ARK Investment Management
North America, New York, United States, New York
Co-Investments: 1

Which angels does Quest Diagnostics often collaborate with?

WH
North America, California, United States, San Francisco
Shared Deals: 1

What are some of recent deals done by Quest Diagnostics?

PreciseDx

New York, New York, United States

PreciseDx is the only Cancer Risk Stratification company to provide patient-specific risk information through the analysis of morphology.

Health Care
Series BAug 21, 2024
Amount Raised: $20,700,000
Universal Diagnostics

Sevilla, Andalucia, Spain

Universal Diagnostics is a biotechnology firm that develops minimally invasive, blood-based solutions for the early detection of cancer.

BiopharmaBiotechnologyMedical
Series BAug 19, 2024
Freenome

South San Francisco, California, United States

Freenome is a biotechnology company with a comprehensive multiomics platform for cancer detection using a routine blood draw.

BiotechnologyHealth CareHealth DiagnosticsPersonal Health
Series UnknownFeb 15, 2024
Amount Raised: $254,000,000
Universal Diagnostics

Seville, Andalucia, Spain

UDX is an in-vitro diagnostics company developing a platform of minimally-invasive, blood-based solutions for the early detection of cancer

BiopharmaBiotechnologyMedical
Series BNov 20, 2023
Amount Raised: $70,221,214
SomaLogic

Boulder, Colorado, United States

SomaLogic is a protein biomarker discovery and clinical diagnostics company, offers SOMAmer technology to improve diagnostic products.

BiotechnologyHealth CareHealth DiagnosticsMedical Device
Series UnknownJan 3, 2018
Amount Raised: $200,000,000
Lemonaid Health

San Francisco, California, United States

Lemonaid Health is a telemedicine platform that uses technology to change the way people interact with health care.

Artificial Intelligence (AI)Health CareMachine LearningMedicalTelehealth
Series AMay 22, 2017
Amount Raised: $11,000,000